Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Clinicopathological Features of Telbivudine-Associated Myopathy.

Ambang T, Tan JS, Ong S, Wong KT, Goh KJ.

PLoS One. 2016 Sep 9;11(9):e0162760. doi: 10.1371/journal.pone.0162760. eCollection 2016.

2.

Telbivudine myopathy in a patient with chronic hepatitis B.

Wang M, Da Y, Cai H, Lu Y, Wu L, Jia J.

Int J Clin Pharm. 2012 Jun;34(3):422-5. doi: 10.1007/s11096-012-9633-3. Epub 2012 Apr 17.

PMID:
22527478
3.

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.

Kim EH, Park H, Lee KH, Ahn SH, Kim SM, Han KH.

Clin Mol Hepatol. 2013 Mar;19(1):82-6. doi: 10.3350/cmh.2013.19.1.82. Epub 2013 Mar 25.

4.

Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine.

Zou XJ, Jiang XQ, Tian DY.

J Viral Hepat. 2011 Dec;18(12):892-6. doi: 10.1111/j.1365-2893.2010.01412.x. Epub 2010 Dec 23.

PMID:
22093034
5.

Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.

Turan I, Yapali S, Bademkiran F, Kose T, Duman S, Sozbilen M, Gunsar F, Ersoz G, Akarca US, Ozutemiz O, Karasu Z.

Liver Transpl. 2015 Aug;21(8):1066-75. doi: 10.1002/lt.24131. Epub 2015 Jun 23.

6.

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.

Ying Y, Hu YK, Jin JL, Zhang JM, Zhang WH, Huang YX.

BMC Gastroenterol. 2018 Apr 6;18(1):45. doi: 10.1186/s12876-018-0773-3.

7.

Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.

Jin JL, Hu P, Lu JH, Luo SS, Huang XY, Weng XH, Zhang JM.

World J Gastroenterol. 2013 Sep 7;19(33):5575-80. doi: 10.3748/wjg.v19.i33.5575. Review.

8.

Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion.

Xu H, Wang Z, Zheng L, Zhang W, Lv H, Jin S, Yuan Y.

J Clin Pathol. 2014 Nov;67(11):999-1005. doi: 10.1136/jclinpath-2013-202069. Epub 2014 Sep 4.

9.

Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.

Fung J, Seto WK, Lai CL, Yuen MF.

J Gastroenterol Hepatol. 2014 Mar;29(3):428-34. doi: 10.1111/jgh.12499. Review.

PMID:
24372662
10.
11.

Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis.

Dang S, Gao N, Zhang X, Jia X.

Am J Med Sci. 2011 Jul;342(1):73-5. doi: 10.1097/MAJ.0b013e31821a520e.

PMID:
21642814
12.

Cumulative incidence and risk factors of creatine kinase elevation associated with telbivudine.

Chen L, Cheng C, Chen B, Zhao Y, Zhang J, Wang B.

Eur J Clin Pharmacol. 2016 Feb;72(2):235-41. doi: 10.1007/s00228-015-1978-9. Epub 2015 Nov 14.

PMID:
26566799
13.

The Ca2+/CaMKK2 axis mediates the telbivudine induced upregulation of creatine kinase: Implications for mechanism of antiviral nucleoside analogs' side effect.

Jianfei L, Min W, Chunlai M, Bicui C, Jiming Z, Bin W.

Biochem Pharmacol. 2017 Dec 15;146:224-232. doi: 10.1016/j.bcp.2017.10.005. Epub 2017 Oct 14.

PMID:
29038020
14.

Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.

Wang L, Chen H, Fan C, Gong Z.

J Med Virol. 2013 Nov;85(11):1907-12. doi: 10.1002/jmv.23689. Epub 2013 Jul 12.

PMID:
23852947
15.

Dysphagia could be the first presenting symptom of telbivudine-induced myopathy.

Lee SW, Jang JH, Kim BJ.

Intern Med J. 2013 Sep;43(9):1048-9. doi: 10.1111/imj.12237. No abstract available.

PMID:
24004397
16.

Prognosis in AZT myopathy.

Chalmers AC, Greco CM, Miller RG.

Neurology. 1991 Aug;41(8):1181-4.

PMID:
1714057
17.

Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy.

Tak WY, Park SY, Cho CM, Jung MK, Jeon SW, Kweon YO, Park JY, Sohn YK.

J Hepatol. 2010 Aug;53(2):261-6. doi: 10.1016/j.jhep.2010.03.006. Epub 2010 Apr 18.

PMID:
20466447
18.

Determination of telbivudine in the plasma of chronic hepatitis B patients in long-term treatment by high-performance liquid chromatographic-tandem mass spectrometry.

Chen B, Chen L, Cheng C, Zhong M, Shi X, Zhang J, Wang B.

Biomed Chromatogr. 2018 Apr;32(4). doi: 10.1002/bmc.4140. Epub 2018 Jan 3.

PMID:
29148589
19.

Clinical features of adverse reactions associated with telbivudine.

Zhang XS, Jin R, Zhang SB, Tao ML.

World J Gastroenterol. 2008 Jun 14;14(22):3549-53.

20.

[The clinical and muscular pathological features of statin-induced myopathy].

Meng L, Lu Y, Zhang W, Wang Z, Lyu H, Yuan Y.

Zhonghua Nei Ke Za Zhi. 2015 Aug;54(8):716-20. Chinese.

PMID:
26674629

Supplemental Content

Support Center